Evaluation of the Potential Association Between 5α-reductase Inhibitors Prescription and Occurrence of High Grade Prostate Cancers

计划入组 5,154 人 · 首次发布于 2016 年 8 月 19 日

Effect of Different Dosing Regimens of Tadalafil or Tamsulosin Combined With 5α-Reductase Inhibitors on Urinary and Sexual Outcomes in Benign Prostatic Hyperplasia

计划入组 240 人 · 首次发布于 2026 年 7 月 20 日

Bioavailability Study of SPARC001 (Study 2) in Healthy Adult Volunteers

计划入组 24 人 · 首次发布于 2016 年 12 月 13 日

H TYPE II TRISACCHARIDE

C₂₀H₃₅NO₁₅

antibody therapeutics (type II diabetes)

Type II collagen(Pharming Group NV)

Celgene International II SARL

Switzerland

Meiragtx UK II Ltd.

Belgium

Generics Bidco II, LLC

United States

Cutia Therapeutics Receives NMPA Approval for Topical Dutasteride Clinical Trial in Androgenetic Alopecia

Dayspring Pharma's CG2001 Foam Shows 50% Efficacy Improvement in Phase II Androgenetic Alopecia Trial

Nanopharmaceutics Completes Phase II Enrollment for Triapine Combination Therapy in Neuroendocrine Tumors